ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Extrawell Pharmaceutical Holdings Ltd. ?
Unrated Stock - No Analysis Available
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-6.50%
EBIT Growth (5y)
8.79%
EBIT to Interest (avg)
-0.74
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.66
Sales to Capital Employed (avg)
0.06
Tax Ratio
0.51%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.22
EV to EBIT
75.23
EV to EBITDA
-585.11
EV to Capital Employed
-1.27
EV to Sales
-10.56
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-2.00%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bullish
Bearish
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
NET PROFIT(HY)
Higher at HKD -18.18 MM
ROCE(HY)
Highest at 23.02%
CASH AND EQV(HY)
Highest at HKD 1,015.24 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -65.51 %
EPS(Q)
Highest at HKD 0.04
-5What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 11.01% (YoY
NET SALES(Q)
Lowest at HKD 24.64 MM
INTEREST(Q)
Highest at HKD 11.48 MM
PRE-TAX PROFIT(Q)
Lowest at HKD -16.29 MM
NET PROFIT(Q)
Lowest at HKD -18.18 MM
Here's what is working for Extrawell Pharmaceutical Holdings Ltd.
EPS
Highest at HKD 0.04
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (HKD)
Cash and Eqv
Highest at HKD 1,015.24 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at -65.51 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Extrawell Pharmaceutical Holdings Ltd.
Net Sales
Lowest at HKD 24.64 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (HKD MM)
Interest
Highest at HKD 11.48 MM
in the last five periods and Increased by 8.01% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (HKD MM)
Pre-Tax Profit
Lowest at HKD -16.29 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (HKD MM)
Net Profit
Lowest at HKD -18.18 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (HKD MM)
Raw Material Cost
Grown by 11.01% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
